These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33836207)

  • 1. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
    Feng JL; Qin X
    Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study.
    Feng JL; Qin X
    Eur J Clin Pharmacol; 2021 Mar; 77(3):399-407. PubMed ID: 33030570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does adherence to lipid-lowering medications improve cancer survival? A nationwide study of breast and colorectal cancer, and melanoma.
    Feng JL; Qin X
    Br J Clin Pharmacol; 2021 Apr; 87(4):1847-1858. PubMed ID: 33084072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
    Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
    Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postdiagnostic metformin use and survival of patients with colorectal cancer: A Nationwide cohort study.
    Huang WK; Chang SH; Hsu HC; Chou WC; Yang TS; Chen JS; Chang JW; Lin YC; Kuo CF; See LC
    Int J Cancer; 2020 Oct; 147(7):1904-1916. PubMed ID: 32196659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
    Zhang ZJ; Li S
    Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
    Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
    Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do endometrial cancer patients benefit from metformin intake?
    Lemańska A; Zaborowski M; Spaczyński M; Nowak-Markwitz E
    Ginekol Pol; 2015 Jun; 86(6):419-23. PubMed ID: 26255448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
    Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication.
    Arima R; Hautakoski A; Marttila M; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Hinkula M; Puistola U; Läärä E
    Gynecol Oncol; 2017 Dec; 147(3):678-683. PubMed ID: 29054569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
    Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
    J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
    Insin P; Prueksaritanond N
    Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of metformin in patients with endometrial cancer: a retrospective study.
    Seebacher V; Bergmeister B; Grimm C; Koelbl H; Reinthaller A; Polterauer S
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():291-6. PubMed ID: 27423029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
    Spillane S; Bennett K; Sharp L; Barron TI
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.